Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Queensland Health
Daiichi Sankyo
Argus Health
US Army

Generated: July 20, 2017

DrugPatentWatch Database Preview

Warfarin sodium - Generic Drug Details

« Back to Dashboard

What are the generic sources for warfarin sodium and what is the scope of warfarin sodium patent protection?

Warfarin sodium
is the generic ingredient in five branded drugs marketed by Taro Pharm, Amneal Pharms, Ipca Labs Ltd, Mylan, Usl Pharma, Pliva, Bristol Myers Squibb, Watson Labs, Abbott, Invagen Pharms, Barr, Zydus Pharms Usa, Pharm Res Assoc, and Sandoz, and is included in twenty-one NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are twenty-two drug master file entries for warfarin sodium. Forty suppliers are listed for this compound.

Summary for Generic Name: warfarin sodium

Drug Master File Entries: see list22
Suppliers / Packagers: see list40
Bulk Api Vendors: see list48
Clinical Trials: see list2,739
Patent Applications: see list6,135
Therapeutic Class:Blood Products/Modifiers/ Volume Expanders
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:warfarin sodium at DailyMed

Pharmacology for Ingredient: warfarin sodium

Drug ClassVitamin K Antagonist
Mechanism of ActionVitamin K Inhibitors
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Taro Pharm
warfarin sodium
TABLET;ORAL040301-005Jul 15, 1999ABRXNoNo► Subscribe► Subscribe
warfarin sodium
TABLET;ORAL040616-002Jul 5, 2006ABRXNoNo► Subscribe► Subscribe
warfarin sodium
TABLET;ORAL040196-005Sep 30, 1997DISCNNoNo► Subscribe► Subscribe
Bristol Myers Squibb
warfarin sodium
INJECTABLE;INJECTION009218-020Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Bristol Myers Squibb
warfarin sodium
TABLET;ORAL009218-022Mar 1, 1990ABRXYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Argus Health
Farmers Insurance
US Department of Justice
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:

Google Plus